View more job listings or post a job
Gilead Sciences Senior Research Associate, Drug Metabolism
Gilead Sciences Research Scientist, Drug Metabolism
Gilead Sciences Principal Scientist, Drug Metabolism
Gilead Sciences Research Scientist, Drug Metabolism
Theravance Biopharma Associate Scientist
Gilead Sciences Associate Scientist (Contractor)
Evotec/Genentech Contractor Scientific Researcher/Sr. Scientific Researcher in Protein Chemistry
Evotec/Genentech Contractor Scientific Researcher/Sr. Scientific Researcher in Protein Chemistry
Applied Photophysics Application Scientist
Genentech Associate Scientist(Contract)
Post a job


Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)

Speakers: Alex Franzusoff (PACT Pharma); David Kirn (4D Molecular Therapeutics); Wei Lin (Nektar); Fred Ramsdell (Parker Inst); Terri McClanahan (Merck); William Overwijk (ex MD Anderson); Stephen Becker (Bryologyx)
Date: 6/11/2019
Time: 8:45-17:00
Registration fee (USD): Regular: $195; Academic: $125; Students & Unemployed: $35;
Location: Crowne Plaza, Foster City, CA
Major Sponsor: (1)KCAS Bioanalytical & Biomarker Services;(Major Sponsorship - Afternoon still open)
Vendor show vendors registered to date: (3)Novogene Corporation; Viracor Eurofins; WuXi Apptec
Registration deadline:6/11/2019  (it will close sooner if the seating cap is reached)

About the Topic

The last few years has seen major advancements in cancer treatment through immunotherapy. This symposium aims to provide a comprehensive overview of the emerging concepts in cancer immunotherapy from the latest biologic insights in academia, to the latest clinical data for approved and investigational immuno-oncology agents. We will discuss the latest partnership trends and business development efforts in this rapidly evolving landscape.

Tentative topics include:

-oncolytic viruses
-CAR-T therapy
-TGFbeta and the tumor microenvironment
-neoantigens cancer vaccines
-TCR therapy
-novel combinations with checkpoint inhibitors

About the Speakers


Alex Franzusoff, CEO (PACT Pharma)
David Kirn, CEO (4D Molecular Therapeutics)
Wei Lin, MD, SVP of Clinical Dev (Nektar)
Fred Ramsdell, Chief Scientific Officer (Parker Inst)
Terri McClanahan, Exec Director (Merck)
William Overwijk (ex MD Anderson)
Stephen Becker, Chief Medical Officer (Bryologyx)

2019-03-07, Promising Therapeutic Approaches and Translational Medicine to Advance Novel Therapeutics (A Joint Symposium by PBSS and Stanford SPARK Program)
2019-03-11, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2019-04-25, Tox 21 and New Approach Methodology (NAMs): Using Emerging Technologies to Improve Translational Research and Safety Assessment Predictions (jointly by SOT-NorCal & PBSS)
2019-05-06, CMC Development for Biologics: Purification, Formulation, Analytical Characterization, Production Systems, Regulatory and Product Development
2019-09-13, Biotransformation and Disposition of Larger Molecules: Peptides, Nucleotides, Proteins, mAbs, and ADCs
2019-10-03, Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends
┬ęPharmaceutical & BioScience Society, International; Last Modified: 2/23/2019; Visited: 482; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Submit a Text Ad